A Leading Global Supplier of Radiopharmaceutical Precursors

ABX develops and produces compounds and components for every type of radiotracer - from PET and SPECT precursors, PET reagent kits and cassettes to complete radiopharmaceutical drug production in a GMP environment.

The team of more than 350 employees specializes in the custom synthesis and manufacture of precursors and peptides according to GMP for active pharmaceutical ingredients. Thanks to unique expertise combined with state-of-the-art equipment, ABX achieves the highest research, production and quality standards. For example, the company operates a hot cell laboratory for the research and development of new radiopharmaceutical kits and cassettes for its own product portfolio and for collaboration with pharmaceutical companies.

Extensive laboratory space makes it possible to carry out stability studies on the company's own products and internal sterility tests on radioactive drugs. Thanks to the production of aseptic excipients and sterile disposables, ABX is largely independent of external suppliers.

ABX is also an authorized manufacturer of radiopharmaceutical drugs and an expert in ASMFs, US DMFs and technical documents for reagent kits, cassettes, PET and SPECT precursors.

ABX is a global success story: as one of the market leaders for radiopharmaceutical consumables, the company has developed the ¹⁷⁷Lu-PSMA-617 to Phase II (then sublicensed to Endocyte, now Novartis) in recent years - as well as bringing ¹⁸F-PSMA-1007 to approval in selected European countries.